Jean M. Whaley

5.8k total citations · 2 hit papers
32 papers, 3.7k citations indexed

About

Jean M. Whaley is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jean M. Whaley has authored 32 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Jean M. Whaley's work include Diabetes Treatment and Management (16 papers), Pancreatic function and diabetes (12 papers) and Metabolism, Diabetes, and Cancer (9 papers). Jean M. Whaley is often cited by papers focused on Diabetes Treatment and Management (16 papers), Pancreatic function and diabetes (12 papers) and Metabolism, Diabetes, and Cancer (9 papers). Jean M. Whaley collaborates with scholars based in United States, Germany and United Kingdom. Jean M. Whaley's co-authors include Scott C. Thomson, Volker Vallon, Timo Rieg, Deborah Hagan, Nikolai Kley, James F. List, David N. Louis, Richard Y. Chung, Bernd R. Seizinger and Kenneth A. Platt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Diabetes.

In The Last Decade

Jean M. Whaley

32 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule

2010 446 citations Volker Vallon, Kenneth A. Platt et al. Journal of the American Society of Nephrology profile →
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix

1998 395 citations Michael Ohh, Robert L. Yauch et al. Molecular Cell profile →

Peers

Jean M. Whaley

EDM

SURGE

ONCOL

Mercedes Robledo Spain

Sophie Giorgetti‐Peraldi France

Ding Ai China

Kristof Graf Germany

Minako Ishibashi Japan

Denis deBlois Canada

Motohide Isono Japan

Kerri Thai Canada

Hartmut Rütten Germany

Masako Mitsumata Japan

Mercedes Robledo Spain

Jean M. Whaley

2.2k ×1.2

2.2k ×1.4

EDM

2.1k ×1.8

SURGE

2.2k ×2.8

1.2k ×2.1

ONCOL

Citations per year, relative to Jean M. Whaley Jean M. Whaley (= 1×) peers Mercedes Robledo

Countries citing papers authored by Jean M. Whaley

Since Specialization

Citations

This map shows the geographic impact of Jean M. Whaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean M. Whaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean M. Whaley more than expected).

Fields of papers citing papers by Jean M. Whaley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean M. Whaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean M. Whaley. The network helps show where Jean M. Whaley may publish in the future.

Co-authorship network of co-authors of Jean M. Whaley

This figure shows the co-authorship network connecting the top 25 collaborators of Jean M. Whaley. A scholar is included among the top collaborators of Jean M. Whaley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean M. Whaley. Jean M. Whaley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hinke, Simon A., Thomas Kirchner, Katharine D’Aquino, et al.. (2018). Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody. Molecular Metabolism. 10. 87–99. 12 indexed citations

Jurczak, Michael J., et al.. (2018). SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice. Islets. 10(5). 181–189. 11 indexed citations

Reilly, Timothy P., Michael J. Graziano, Evan B. Janovitz, et al.. (2014). Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus. Diabetes Therapy. 5(1). 73–96. 55 indexed citations

Jabbour, Serge, Jean M. Whaley, Mark A. Tirmenstein, et al.. (2012). Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin. Postgraduate Medicine. 124(4). 62–73. 12 indexed citations

Whaley, Jean M., et al.. (2012). Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 5. 135–135. 52 indexed citations

Thomson, Scott C., Timo Rieg, Cynthia M. Miracle, et al.. (2011). Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 302(1). R75–R83. 239 indexed citations

List, James F. & Jean M. Whaley. (2011). Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans. Kidney International. 79(120). S20–S27. 147 indexed citations

Chen, Jian, Sandy Williams, Samantha Ho, et al.. (2010). Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Therapy. 1(2). 57–92. 250 indexed citations

Jones, H. B., et al.. (2010). The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats. Diabetes Obesity and Metabolism. 12(11). 1004–1012. 74 indexed citations

10.

Vallon, Volker, Kenneth A. Platt, Robyn Cunard, et al.. (2010). SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule. Journal of the American Society of Nephrology. 22(1). 104–112. 446 indexed citations breakdown →

11.

Ellsworth, Bruce A., Wei Meng, Manorama M. Patel, et al.. (2008). Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2. Bioorganic & Medicinal Chemistry Letters. 18(17). 4770–4773. 43 indexed citations

12.

Naglich, Joseph G., et al.. (1999). Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity. Oncogene. 18(8). 1529–1535. 108 indexed citations

13.

Ohh, Michael, Robert L. Yauch, Kim M. Lonergan, et al.. (1998). The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix. Molecular Cell. 1(7). 959–968. 395 indexed citations breakdown →

14.

Kley, Nikolai, et al.. (1995). Neurofibromatosis type 2 and von Hippel‐Lindau disease: From gene cloning to function. Glia. 15(3). 297–307. 8 indexed citations

15.

Whaley, Jean M., Joseph G. Naglich, & Lawrence M. Gelbert. (1994). Germline mutations in the VHL tumor suppresssor gene are similar to somatic VHL aberrations in sporadic renal cell carcinoma. The American Journal of Human Genetics. 55. 1 indexed citations

16.

Louis, David N., Andreas von Deimling, Richard Y. Chung, et al.. (1993). Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors. Journal of Neuropathology & Experimental Neurology. 52(1). 31–38. 195 indexed citations

17.

Wullich, Bernd, Jean M. Whaley, Guillermo A. Herrera, et al.. (1992). Cytogenetic and molecular studies of a familial renal cell carcinoma. Cancer Genetics and Cytogenetics. 63(1). 25–31. 6 indexed citations

18.

Chung, Richard Y., Jean M. Whaley, Nikolai Kley, et al.. (1991). TP53 Gene Mutations and 17p Deletions in Human Astrocytomas. Genes Chromosomes and Cancer. 3(5). 323–331. 118 indexed citations

19.

Whaley, Jean M., Amin I. Kassis, Berma M. Kinsey, S. James Adelstein, & John B. Little. (1990). Mutation Induction by ¹²⁵ iodoacetylproflavine, a DNA-intercalating Agent, in Human Cells. International Journal of Radiation Biology. 57(6). 1087–1103. 9 indexed citations

20.

Whaley, Jean M. & John B. Little. (1990). Molecular characterization of hprt mutants induced by low- and hgh-LET radiations in human cells. Mutation Research Letters. 243(1). 35–45. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact